Clinical Trial: Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922720) titled 'Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors' on Sept. 17.

Brief Summary: Living donor liver transplantation (LDLT) is a critical therapeutic modality for patients with end-stage liver disease and hepatic malignancies. However, the donor's surgical safety is paramount, and the presence of hepatic steatosis frequently precludes potential donors from qualifying for donation due to risks for both donor and recipient. With the rising prevalence of fatty liver disease, an increasing number of candidate donors are excluded during screening, complicating timely transplantation for urgent recipients....